UPDATE: Chardan Capital Markets Starts Silence Therapeutics (SLN) at Buy
Tweet Send to a Friend
(Updated - March 31, 2022 7:57 AM EDT)
Chardan Capital Markets analyst Keay Nakae initiates coverage on Silence Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Chardan Capital Markets analyst Keay Nakae initiates coverage on Silence Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
